Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Часто задаваемые вопросы
В каком секторе работает Champions Oncology, Inc (CSBR)?
Champions Oncology, Inc относится к сектору Здравоохранение.
Какова текущая цена акций Champions Oncology, Inc (CSBR)?
По последним данным, цена акций Champions Oncology, Inc составляет 4,90 $, предыдущее закрытие — 4,95 $. За последнюю торговую сессию акции Champions Oncology, Inc снизились на -0,05 $, что соответствует падению на -1,01%.
Выплачивает ли Champions Oncology, Inc (CSBR) дивиденды?
Нет, Champions Oncology, Inc не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Champions Oncology, Inc (CSBR)?
У компании Champions Oncology, Inc бета 0.403, что указывает на более низкую волатильность по сравнению с рынком в целом.
